VPC
TENX icon

Vestal Point Capital’s Tenax Therapeutics TENX Stock Holding History

Vestal Point Capital’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$854K Hold
53,439
– – 0.02% 87
2025
Q4 		$651K Hold
53,439
– – 0.02% 74
2025
Q3 		$407K Hold
53,439
– – 0.02% 80
2025
Q2 		$308K Hold
53,439
– – 0.02% 71
2025
Q1 		$350K Sell
53,439
-1,750
-3% -$11.2K 0.03% 62
2024
Q4 		$342K Sell
55,189
-28,144
-34% -$137K 0.02% 73
2024
Q3 		$288K Buy
+83,333
New +$302K 0.02% 69

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vestal Point Capital's TENX Position: Q1 2026 in Review

Vestal Point Capital held its Tenax Therapeutics (TENX) position steady in Q1 2026 at 53,439 shares worth $854K. The position accounts for 0.02% of the portfolio, ranked #87.

Vestal Point Capital first reported a position in TENX in Q3 2024 and has held it in 7 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Vestal Point Capital held 53,439 shares of Tenax Therapeutics worth $854K as of Q1 2026.
  • Vestal Point Capital left its Tenax Therapeutics share count unchanged in Q1 2026.
  • Tenax Therapeutics made up 0.02% of Vestal Point Capital's portfolio in Q1 2026, its #87 holding.
  • Vestal Point Capital first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.